Cargando…
Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM–camptothecin conjugate
The efficient targeting of drugs to tumor cell and subsequent rapid drug release remain primary challenges in the development of nanomedicines for cancer therapy. Here, we constructed a glucose transporter 1 (GLUT1)-targeting and tumor cell microenvironment-sensitive drug release Glucose–PEG–PAMAM-s...
Autores principales: | Ma, Pengkai, Sun, Yi, Chen, Jianhua, Li, Hongpin, Zhu, Hongyu, Gao, Xing, Bi, Xinning, Zhang, Yujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058575/ https://www.ncbi.nlm.nih.gov/pubmed/29282992 http://dx.doi.org/10.1080/10717544.2017.1419511 |
Ejemplares similares
-
GLUT1 targeting and hypoxia-activating polymer-drug conjugate-based micelle for tumor chemo-thermal therapy
por: Ma, Pengkai, et al.
Publicado: (2021) -
Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates
por: Pyreddy, Suneela, et al.
Publicado: (2014) -
Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells – Possible Role of GLUT1 Transporter
por: Sztandera, Krzysztof, et al.
Publicado: (2019) -
Hepatocyte-targeting and tumor microenvironment-responsive liposomes for enhanced anti-hepatocarcinoma efficacy
por: Cheng, Dongliang, et al.
Publicado: (2022) -
In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates
por: Najlah, Mohammad, et al.
Publicado: (2017)